Cheng Du Sheng Nuo Biotec Hits Day High with 6.26% Surge

Cheng Du Sheng Nuo Biotec Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 6.26% as of September 30, 2025. The stock reached an intraday high of CNY 42.00, reflecting its robust performance in the market.
Over the past year, Cheng Du Sheng Nuo Biotec has delivered an impressive return of 113.23%, significantly outperforming the China Shanghai Composite, which recorded a 25.1% increase during the same period. The company's year-to-date performance stands at 123.12%, further highlighting its strong market position.

Financial metrics indicate a return on equity (ROE) of 11.78%, with a price-to-book ratio of 5.99. The stock's performance over the last three years has also been notable, with a return of 79.67%, again surpassing the China Shanghai Composite's 27.01% growth.

Despite a slight decline of 3.17% over the past month, the overall trend suggests that Cheng Du Sheng Nuo Biotec Co. continues to maintain a competitive edge in its industry, supported by solid profit growth of 62.8% over the last year.